s

Current Issue

Vol. 1 No. 1 (2022): Jurnal Pharmactive April
					View Vol. 1 No. 1 (2022): Jurnal Pharmactive April

Jurnal Pharmactive Edisi April 2022 memuat 7 artikel ilmiah dengan tema farmasi sosial, bahan alam, klinis, dan teknologi farmasi. Penulis artikel pada edisi ini berasal dari 2 instansi pendidikan yaitu Akademi Kesehatan Bintang Persada dan STIKes Bali Wisnu Dharma, serta dari Fasilitas Kesehatan Puskesmas Karangasem I.

Published: 2022-04-08
View All Issues


 Journal title
 Initials
 Frequency
 DOI
 E-ISSN
 Editor-in-chief
 Publisher
 Indexing

: Journal Pharmactive
: JPharmactive 
2 issues per year
: - by
: 2829-3444
: apt. Putu Ika Indah Indraswari, M.Farm.
: LPPM Akademi Kesehatan Bintang Persada

Journal Pharmactive is an open access journal maintained by Program Studi Farmasi Akademi Kesehatan Bintang Persada and published twice a year in April and September. is a forum for research on all aspects of pharmaceutical science that are innovative, creative, original. and scientifically based.

The articles in this journal are about pharmaceutical care, complementary herbal medicines, and cosmetics with special fields, including:

  1. Clinical and Community Pharmacy
  2. Pharmaceutical Analysis
  3. Herbal Medicine
  4. Pharmaceutical Technology
  5. Management of Pharmacy

All articles in Journal Pharmactive will be processed by the editor through the Online Journal System (OJS), and the author can monitor the entire process in the member area. Articles published in Journal Pharmactive, both in hardcopy and soft copy, are available as open access licensed under a Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) for educational, research and library purposes, and beyond that purpose, the Journal Pharmactive editorial board is not responsible for copyright infringement.

We invite you to submit and collect articles / papers on Journal Pharmactive. The collection of articles in the Journal Pharmactive opens year-round and will be published twice a year in April and October. We do Double BLIND REVIEW to maintain quality publications.